期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

细菌药敏试验的更高目标——个体化药敏试验报告 被引量：2

原文传递
导出
摘要 临床感染菌的耐药性不断增强使细菌的药敏试验的重要性日益提高。检验科负有向临床提供准确、可靠的合理用药信息的责任。我国已将美国临床和实验室标准化协会（Clinical and Laboratory Standards Institute，CLSI）的标准化文件作为国标。
作者 王金良
机构地区 天津市公安医院检验科
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2012年第8期764-765,共2页 Chinese Journal of Laboratory Medicine
关键词 药敏试验报告 细菌药敏试验 LABORATORY 个体 用药信息 标准化 耐药性 感染菌
分类号 R446.5 [医药卫生—诊断学]
  • 相关文献

参考文献10

二级参考文献71

  • 1马越,金少鸿.细菌耐药性监测中质量控制的若干问题[J].中华检验医学杂志,2004,27(11):721-723. 被引量：55
  • 2王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量：183
  • 3Cornaglia G, Lonnroth A, Struelens M. Report from the European Conference on the Role of Research in Combating Antibiotic Resistance, 2003. Clin Microbiol Infect, 2004, 10:473-497.
  • 4Marchese A,Schito GC. Role of global surveillance in combating bacterial resistance. Drugs, 2001,61:167-173.
  • 5Jones RN, Craig WA, Ambrose PG, et al. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta- lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases. Diagn Microbiol Infect Dis, 2005, 52:235-246.
  • 6Pottumarthy S, Deshpande LM, Sader HS, et al. Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms. Diagn Microbiol Infect Dis, 2005, 52:95-99.
  • 7Clinical and Laboratory Standards Institute (Fomerly NCCLS ) M100-S18. Performance standards for antimierobial susceptibility testing; Eighteenth Informational Supplement. Wayne, PA 2008.
  • 8Rogues AM, Dumartin C, Amadeo B, et al. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect Control Hosp Epidemiol, 2007, 28 : 1389-1395.
  • 9Meyer E, Schwab F, Gastmeier P,et al. MethieiUin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of antimicrobial use and antimicrobial resistance in intensive care units). Infect Control Hosp Epidemiol, 2006, 27: 146-154.
  • 10D'costo VM, McGrann KM, Hughes DW, et al. Soil microbes are Veservoir for antibiotic resistance. Science, 2006, 311:374-377.

共引文献54

同被引文献24

  • 1杨启文,徐英春.诱导型AmpC酶和结构型AmpC酶的检测与产酶菌株感染的治疗进展[J].中华检验医学杂志,2005,28(4):457-460. 被引量：17
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量：3056
  • 3Dellit T H, Owens R C, McGowan J E Jr,et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to en- hance antimicrobial stewardship[J]. Clin Infect Dis, 2007, 44(2): 159-177.
  • 4Schwaber M J,Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-1actamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis[J]. J Antimicrob Chemother,2007, 60(5):913-920.
  • 5Gary V D,Stephen M B.The clinical predictive value (or lack there- of) of the results of in vitro antimicrobial susceptibility tests [J].J Clin Microbiol, 2011,49(9): $11-$14.
  • 6Bruins M J, Ruijs G J, Wolfhagen M J, et al. Does electronic clinica microbiology results reporting influence medical decision making: a pre- and post-interview study of medical specialists[J]. BMC Med Inform Decis Mak,2011,11:19.
  • 7王金良.新传染病的快速诊断要求发展微生物检验新技术.实用检验医师杂志,2009,1:2-5.
  • 8Long SW, Williams D, Valson C, et al. A genomic day in the life of a clinical microbiology laboratory. J Clin Mierobiol,2013,51:1272- 1277.
  • 9Rifai N, Diamandis EP, Lo YM, et al. Advancing laboratory medicine through innovation : a tale of six inventors. Clin Chem, 2012,58 : 502- 510.
  • 10丛玉隆,总主编.实用检验医学.第2版(下册),北京:人民卫生出版社,2014,921.

引证文献2

二级引证文献12

中华检验医学杂志
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部